[关键词]
[摘要]
目的:探讨CD44变异剪接异构体9(CD44v9)对卵巢癌细胞迁移与侵袭能力的影响并初步分析其机制。方法:采用免疫组织化学法及Western blotting法检测卵巢癌组织及细胞中CD44v9的表达水平。将CD44v9-shRNA质粒转染至卵巢癌细胞 OVCAR-3与SKOV3,敲低细胞中CD44v9的表达后,通过划痕愈合实验、Transwell细胞迁移、侵袭实验检测细胞迁移和侵袭能力的变化;免疫荧光和Western blotting实验检测OVCAR-3和SKOV3细胞中缺氧诱导因子-1α(HIF-1α)、Ras样无CAAX基序蛋白1 (RIT1)的表达。转染HIF-1α过表达质粒(HIF-1α-OE)进行功能回复实验,检测HIF-1α过表达对CD44v9敲低所致细胞迁移和侵袭能力变化的影响。建立裸鼠异种移植模型与血行转移模型,评估敲低CD44v9对体内肿瘤生长及转移的影响,并采用免疫组织化学检测肿瘤组织中HIF-1α的表达。结果:CD44v9在卵巢癌组织与细胞中呈高表达(P < 0.01)。敲低CD44v9抑制卵巢癌细胞的迁移和侵袭(P < 0.01)并降低HIF-1α和RIT1的表达(P < 0.01)。过表达HIF-1α能部分逆转CD44v9敲低对卵巢癌细胞迁移与侵袭的抑制作用。体内实验显示,敲低CD44v9 抑制小鼠体内卵巢癌移植瘤的生长和血行转移(P < 0.01)并降低肿瘤组织中 HIF-1α的表达。结论:CD44v9在卵巢癌中表达上调,敲低CD44v9可抑制卵巢癌细胞迁移、侵袭及体内肿瘤生长和转移,其机制可能与HIF-1α/RIT1通路有关。
[Key word]
[Abstract]
Objective: To explore the effects of CD44 variant isoform 9 (CD44v9) on the migration and invasion of ovarian cancer cells and to preliminarily analyze its mechanism. Methods: CD44v9 expression patterns in ovarian cancer tissues and cell lines were detected using immunohistochemistry and Western blotting. OVCAR-3 and SKOV3 cells were transfected with either control-shRNA or CD44v9-shRNA plasmids, with transfection efficiency verified by Western blotting. Functional assays including wound healing assay, Transwell migration and invasion assays were performed to assess cell migration and invasion. Immunofluorescence staining and Western blotting were employed to examine hypoxia-inducible factor-1α (HIF-1α) and Ras like without CAAX 1 (RIT1) expression profiles. Further, a rescue experiment was conducted by transfecting the HIF-1α overexpression plasmid (HIF-1α-OE) to determine whether HIF-1α overexpression could reverse the changes in cell migration and invasion induced by CD44v9 knockdown. In vivo antitumor effects were assessed through xenograft and hematogenous metastasis models, with HIF-1α expression in tumor tissues confirmed by immunohistochemistry. Results: CD44v9 showed significantly elevated expression in ovarian cancer specimens and cell lines (all P < 0.01). CD44v9 knockdown markedly impaired tumor cell migration and invasion (all P < 0.01). Mechanistically, CD44v9 knockdown reduced the expression levels of HIF-1α and RIT1 (all P < 0.01). Overexpression of HIF-1α partially reversed the inhibition of migration and invasion caused by CD44v9 knockdown. In vivo experiments demonstrated suppressed tumor growth and metastasis following CD44v9 knockdown (all P < 0.01). Conclusion: CD44v9 is upregulated in ovarian cancer. CD44v9 knockdown inhibits ovarian cancer cell migration and invasion as well as tumor growth and metastasis in vivo, which may be associated with HIF-1α/RIT1 signaling.
[中图分类号]
[基金项目]
新乡医学院三全学院2023年度人才培养项目(SQ2023GGJS02)